abstract |
The present invention provides compounds of formula (I) and their pharmaceutically acceptable salts as shown below: Among them, R 1 , R 2 , L, and Z are each defined in the specification. The present invention also provides a method for reducing blood glucose concentration and treating glucagon-related diseases using the compound of formula (I) or its salts and pharmaceutical compositions containing the same. |